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Re-sequencing of FH genes  
- heterozygous variant in exon 26 of APOB gene 
(c.11477C>T, p.(Thr3826Met) 
       pathogenicity confirmed by functional studies 
           (data  not reported) 
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Background: Familial Hypercholesterolemia (FH) is the most common of all genetic hypercholesterolaemias with 
defects in LDLR, APOB and PCSK9 accounting for the majority of cases. However, there are other rare disorders like 
sitosterolaemia that can present the same phenotype. Both can cause premature atherosclerosis but have distinctive 
dietetic and therapeutic intervention. 
Patient/Proband 
5 year-old referred for: 
 xanthoma 
 severe hypercholesterolemia  
family history of hypercholesterolemia 
Comments: Correct diagnosis of the various causes of hypercholesterolaemia is important because of the different 
dietary and pharmacological interventions in the prevention of atherosclerosis.  
Lipid profile (mg/dL) 
LDL 391 
HDL 34 
TG 89 
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Initial Diagnosis: FH  
Treatment: low saturated fat diet + stanol supplementation + statin  
….but lack of mutations  LDLR, APOB (2 fragments of exons 26 and 29) and PCSK9 genes questioned the diagnosis 
Sitosterolemia? 
- Sterol Chromathography: high plasma levels of 
sitosterol and presence of phytosterols  
- ABCG8 gene analysis: mutation (c.1974C>G, 
p.(Tyr658*) in homozygosity 
- Treatment: low phytosterol diet + ezetimibe 
Follow-up 
1.Cardiovascular and subclinical atheroesclerosis 
assessment:  
- pre-hypertension with non-dipping pattern 
- intima–media thickness (IMT) in P50-75. 
2. Control of LDL levels:  
- combined dietary and therapeutic intervention 
     (sitosterolemia and familial hypercholesterolaemia)  
Family studies: same mutations in several elements 
 
 
 
 
 
 
 
 
 
 
 
 
 
